FDA examines solvent used in production process.
Read More »Yearly Archives: 2019
Long-Term Type 1 Diabetes Associated with Undiagnosed CAD
Higher prevalence of heart disease studied in older people who have type 1.
Read More »7 Minute Workout
The 7 Minute Workout app is the #1 fitness app in 127 countries. Become your own personal trainer to lose weight and get fit with fast, simple daily workouts.
Read More »GDM Linked to Increased Cardiovascular Event Risk Postpartum
In analysis restricted to women who did not develop T2DM, GDM still linked to increased risk
Read More »ACC: Photoplethysmography Signal Can Detect Diabetes
AUC 0.722 for predicting prevalent diabetes in test dataset; negative predictive value 97 percent
Read More »Raspberries May Aid Glucose Control With Prediabetes
With higher raspberry intake, individuals at risk for diabetes needed less insulin to manage blood glucose
Read More »Behavioral Intervention Ups Physical Activity in T2DM
Sustained increase in physical activity, decrease in sedentary time seen with behavioral intervention
Read More »March 5, 2019
Last week, we had some information on the Da Qing Diabetes study, and I mentioned the problem with availability of the most popular ARB’s. Many of you asked for more information and we are completing a special report on what is going on and some possible solutions. Look to our …
Read More »Consider More Accountability as a Treatment for Some Patients
Male, 57 years of age, type 2 diabetes. He started with us 6 months ago. When he started seeing us, he was taking glipizide 10mg twice a day and metformin 1,000 twice daily for his glucose. His A1C was 7.5%, his BMI was 24. We stopped his glipizide and started him on a SGLT-2 and a weekly GLP-1. He met with the dietitian and made some big dietary changes, at least at the start. He also started wearing a CGM and was in our remote monitoring program. He sent me his CGM readings weekly for 4 months. He was doing so well, we decided he need not send me his weekly numbers but rather we’d review during his visits.
Read More »Tim Dunn 2018 Complete Interview
Tim Dunn, Ph.D., is the director of Clinical and Computational Research and an Abbott Volwiler Research Fellow. He also serves as Chair of the Scientific Research Review Committee for investigator-initiated studies. His major areas of expertise are clinical trial strategy and trial design and real-world data analysis.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.